Krebs Biochemicals and Industries Ltd

Stage 1 · Basing · week 1

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. More about the company

₹59.7
+1.46% today
₹129 Cr · Micro cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-16.9%
₹39.8 lo₹71.9 hi
16.9% below 52W high — deeper pullback
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 1
1w13w26w
Week 1 — early base, needs time
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
1.4%
200 DMA: ₹58.9 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
1.13x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑ ⇈
Accelerating · MA20 +3.8% vs MA50 +2.0% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+6.7%
3M
+10.5%
6M
+4.5%
YTD
-16.2%
1Y
-15.9%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
Sector has 77 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Industry has 61 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-07-11 → 2026-10-07
S4 37w
2023-07-112026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 1w → S4 2w → S1 6w → S4 7w → S1 1w → S4 1w → S1 2w → S2 10w → S3 7w → S4 12w → S1 6w → S2 11w → S3 6w → S2 13w → S3 5w → S4 11w → S1 10w → S4 37w → S1 10w → S4 11w → S1 1w current
Total tracked: 168 weeks across 21 stage runs.
Scan Membership
Breakout Watch
Latest: 2024-11-19
2 appearances in last 60 days. First seen: 2024-07-24.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S1
Wk 1 · Vol 1.13x
2026-10-06S1
Wk 1 · Vol 3.19x
2026-10-05S14→1
Wk 1 · Vol 4.27x
2026-10-01S4
Wk 11 · Vol 53.77x
2026-09-30S4
Wk 11 · Vol 4.90x
2026-09-29S4
Wk 11 · Vol 0.60x
2026-09-28S4
Wk 11 · Vol 0.28x
2026-09-25S4
Wk 10 · Vol 0.23x
2026-09-24S4
Wk 10 · Vol 0.31x
2026-09-23S4
Wk 10 · Vol 0.34x
2026-09-22S4
Wk 10 · Vol 0.52x
2026-09-21S4
Wk 10 · Vol 0.66x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹56.4
200 DMA
₹58.9
52W High
₹71.9
52W Low
₹39.8
5D Low
₹58.9
Resistance levels (recent highs)
20d High
₹68.1
60d High
₹68.1
120d High
₹68.1
250d High
₹71.9
Next resistance
+13.9%
to 20d High
Ask the Market AI about KREBSBIOAsk →
About this companyHealth Care· Pharmaceuticals

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.